https://ir.lipocine.com/2025-05-06-Lipocine-Announces-License-and-Supply-Agreement-for-TLANDO-R-in-Brazil
SALT LAKE CITY, May 6, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of...
* Our initial experience with TLANDO TU capsules for the treatment of hypogonadism shows it is safe and efficacious with unique post treatment blood test changes, including a decrease in SHBG in both groups.
* Interestingly, while calculated free testosterone did not change in the “previous...